# US 2024/0181128 A1 · Bioresorbable implant materials and methods of making the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0181128 A1
- Document ID: US20240181128A1
- Status: Published application
- Kind: A1
- Application number: 18/287,475
- Filed: 2022-05-19
- Published: 2024-06-06
- Earliest claimed: 2021-05-19
- Assignees: Georgia Tech Research Corporation
- Applicants: Georgia Tech Research Corporation
- Inventors: Sriharsha Ramaraju; Scott J. Hollister
- Web page: https://patentgrep.com/patent/US20240181128A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- C08L 67/02: Polyesters derived from dicarboxylic acids and dihydroxy compounds (C08L67/06 takes precedence)
- A61F 2/0063: {Implantable repair or support meshes, e.g. hernia meshes}
- A61F 2210/0004: bioabsorbable
- A61F 2210/0038: electromagnetically
- A61F 2240/001: Designing or manufacturing processes
- A61L 2300/604: Biodegradation
- A61L 2400/16: Materials with shape-memory or superelastic properties
- A61L 2430/22: for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
- C08L 2201/06: Biodegradable
- C08L 2201/12: Shape memory
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Disclosed herein are implant materials comprising a shape memory polymer having a first shape and a second shape. The shape memory polymer can comprise at least one monomer unit of glycerol and at least one monomer unit of dodecanedioate and a functionalized surface. The shape memory polymer can take the first shape at a first environmental temperature and the second shape at a second environmental temperature, the second environmental temperature being greater than the first environmental temperature. Also disclosed herein are methods of making the same.

## Claims

### Claim 1

An implant material comprising:
a shape memory polymer comprising:
at least one monomer unit of glycerol and at least one monomer unit of dodecanedioate; and
a functionalized surface.

### Claim 2 (depends on 1)

The implant material of claim 1, wherein the shape memory polymer has a melt transition temperature from approximately 25° C. to approximately 45° C.

### Claim 3 (depends on 1)

The implant material of claim 1, wherein the shape memory polymer takes a first shape at a first environmental temperature;
wherein the shape memory polymer takes a second shape at a second environmental temperature;
wherein the second environmental temperature is greater than the first environmental temperature; and
wherein a melt transition temperature of the shape memory polymer is greater than or equal to the first environmental temperature and less than the second environmental temperature.

### Claim 4 (depends on 2)

The implant material of claim 2, wherein the shape memory polymer is an elastomer above the melt transition temperature and a thermoplastic below the melt transition temperature.

### Claim at position 5

-6. (canceled)

### Claim 7 (depends on 1)

The implant material of claim 1, wherein the functionalized surface comprises a plurality of laser cut suture holes.

### Claim 8 (depends on 1)

The implant material of claim 1, wherein the functionalized surface comprises at least one functional group.

### Claim 9 (depends on 8)

The implant material of claim 8, wherein at least one functional group comprises a bioactive agent.

### Claim 10 (depends on 1)

The implant material of claim 1, wherein the molar ratio of the at least one monomer unit of glycerol to the at least one monomer unit of dodecanedioate is from approximately 10:1 to approximately 1:10.

### Claim 11 (depends on 1)

The implant material of claim 1, wherein the implant material has a biodegradation time when implanted in vivo from approximately 4 months to approximately 24 months.

### Claim 12 (depends on 1)

A method comprising:
forming the implant material of claim 1 into one or more of an implant, a patterned mesh, or a molded medical device.

### Claim 13 (depends on 12)

The method of claim 12, wherein the implant is in a form selected from a group consisting of a sheet, a membrane, a mesh, a sponge, a patch, a molded medical device, and a combination thereof.

### Claim 14

A method comprising:
depositing a shape memory polymer resin into a mold, the shape polymer resin comprising at least one monomer unit of glycerol and at least one monomer unit of dodecanedioate;
partially curing the shape memory polymer resin to form a shape memory elastomer;
cutting the shape memory elastomer; and
curing the shape memory elastomer to form an implant material;
wherein the shape memory elastomer takes a first shape at a first environmental temperature and a second shape at a second environmental temperature;
wherein the second environmental temperature is greater than the first environmental temperature; and
wherein the shape memory elastomer has a melt transition temperature greater or equal to the first environmental temperature and less than the second environmental temperature.

### Claim 15 (depends on 14)

The method of claim 14, wherein one or more of:
the mold comprises one or more patterns having features of at least approximately 5 microns or greater;
the mold has a surface having a treatment thereon;
the mold has a surface with a nonfouling release agent;
the cutting comprises laser cutting the shape memory elastomer into a form factor;
the melt transition temperature is from approximately 25° C. to approximately 45° C.;
the shape memory elastomer is an elastomer in the first shape and a thermoplastic in the second shape;
the molar ratio of the at least one monomer unit of glycerol to the at least one monomer unit of dodecanedioate is from approximately 10:1 to approximately 1:10; or
the implant material has a biodegradation time when implanted in vivo from approximately 4 months to approximately 24 months.

### Claim at position 15

16-17. (canceled)

### Claim 18 (depends on 15)

The method of claim 15, wherein the form factor is selected from a group consisting of a sheet, a membrane, a mesh, a sponge, a patch, a molded medical device, and a combination thereof.

### Claim 19

(canceled)

### Claim 20 (depends on 14)

The method of claim 14, wherein the melt transition temperature is from approximately 31° C. to 35° C.

### Claim at position 19

21-24. (canceled)

### Claim 25 (depends on 14)

The method of claim 14 further comprising laser cutting into a functionalized surface of the shape memory elastomer a plurality of suture holes.

### Claim 26

(canceled)

### Claim 27 (depends on 14)

The method of claim 14, wherein the shape memory elastomer comprises a functionalized surface comprising a bioactive agent.

### Claim at position 23

28-29. (canceled)

### Claim 30 (depends on 14)

The implant material made according to the method of any of claims claim 14.

### Claim 31 (depends on 1)

The implant material of claim 1, wherein one or more of:
the shape memory polymer has a first shape, a second shape, and a melt transition temperature;
the molar ratio of the at least one monomer unit of glycerol to the at least one monomer unit of dodecanedioate is from approximately 10:1 to approximately 1:10;
the shape memory polymer takes the first shape at a first environmental temperature and the second shape at a second environmental temperature, the second environmental temperature being greater than the first environmental temperature;
the melt transition temperature is greater than or equal to the first environmental temperature and less than the second environmental temperature;
the shape memory polymer is an elastomer above the melt transition temperature and a thermoplastic below the melt transition temperature;
the first shape is selected from a group consisting of a curved shape and a tubular shape; or
the second shape is a tubular shape comprising a cut along a longitudinal axis of the implant material;
